KR20230154789A - 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정 - Google Patents

헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정 Download PDF

Info

Publication number
KR20230154789A
KR20230154789A KR1020237018659A KR20237018659A KR20230154789A KR 20230154789 A KR20230154789 A KR 20230154789A KR 1020237018659 A KR1020237018659 A KR 1020237018659A KR 20237018659 A KR20237018659 A KR 20237018659A KR 20230154789 A KR20230154789 A KR 20230154789A
Authority
KR
South Korea
Prior art keywords
formula
compound
group
manufacturing process
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237018659A
Other languages
English (en)
Korean (ko)
Inventor
크리스티안 그루겔
토비아스 웨델
Original Assignee
액티노젠 메디컬 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2020904060A external-priority patent/AU2020904060A0/en
Application filed by 액티노젠 메디컬 리미티드 filed Critical 액티노젠 메디컬 리미티드
Publication of KR20230154789A publication Critical patent/KR20230154789A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B49/00—Grignard reactions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020237018659A 2020-11-06 2021-11-05 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정 Pending KR20230154789A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020904060A AU2020904060A0 (en) 2020-11-06 Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof
AU2020904060 2020-11-06
PCT/AU2021/051310 WO2022094668A1 (en) 2020-11-06 2021-11-05 Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof

Publications (1)

Publication Number Publication Date
KR20230154789A true KR20230154789A (ko) 2023-11-09

Family

ID=81458249

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237018659A Pending KR20230154789A (ko) 2020-11-06 2021-11-05 헤테로고리 메탄온 화합물 및 그의 아자-비시클로 중간체의 제조 공정

Country Status (11)

Country Link
US (1) US20230416243A1 (cg-RX-API-DMAC7.html)
EP (1) EP4240740A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023548368A (cg-RX-API-DMAC7.html)
KR (1) KR20230154789A (cg-RX-API-DMAC7.html)
CN (1) CN116981461A (cg-RX-API-DMAC7.html)
AU (1) AU2021374232A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196642A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023001300A1 (cg-RX-API-DMAC7.html)
IL (1) IL302671A (cg-RX-API-DMAC7.html)
MX (1) MX2023004940A (cg-RX-API-DMAC7.html)
WO (1) WO2022094668A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026509196A (ja) * 2023-03-02 2026-03-17 アクチノゲン メディカル リミテッド アザ二環式ヘテロアリール化合物を調製するための流動化学プロセス
CN121969372A (zh) * 2023-10-03 2026-05-01 射线质医疗有限公司 片剂制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1732552A4 (en) * 2004-01-20 2007-12-19 Merck & Co Inc 2,6-DISUBSTITUTED PIPERIDINES AS MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
MY145633A (en) * 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ES2366058T3 (es) * 2006-03-01 2011-10-14 Theravance, Inc. Compuestos de 8-azabiciclo[3.2.1]octano como antagonistas de los receptores opioides mu.
CA2738453C (en) * 2008-10-23 2017-07-04 Boehringer Ingelheim International Gmbh Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
DK2477983T3 (en) * 2009-09-16 2015-06-29 Univ Edinburgh (4-phenyl-piperidin-1-yl) - [5-1H-pyrazol-4-yl) -thiophene-3-yl] -METHANONFORBINDELSER AND THEIR USE
AU2010331927B2 (en) * 2009-12-17 2013-10-10 Merck Canada Inc. Aminopyrimidines as Syk inhibitors
WO2011090935A1 (en) * 2010-01-19 2011-07-28 Merck Sharp & Dohme Corp. PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
BR112012027640B1 (pt) * 2010-04-29 2021-08-03 The University Of Edinburgh Composto, composição farmacêutica, e, métodos de preparar uma composição farmacêutica, de inibir a função da 11beta-hidroxiesteroide desidrogenase do tipo 1

Also Published As

Publication number Publication date
EP4240740A4 (en) 2024-12-11
US20230416243A1 (en) 2023-12-28
CN116981461A (zh) 2023-10-31
EP4240740A1 (en) 2023-09-13
IL302671A (en) 2023-07-01
MX2023004940A (es) 2023-09-12
AU2021374232A9 (en) 2024-09-26
CA3196642A1 (en) 2022-05-12
WO2022094668A1 (en) 2022-05-12
CL2023001300A1 (es) 2024-01-05
JP2023548368A (ja) 2023-11-16
AU2021374232A1 (en) 2023-06-08

Similar Documents

Publication Publication Date Title
CN118871436A (zh) 可用作抗癌剂的吡唑基衍生物的合成方法
EP3450439B1 (en) Method for producing monomer for single-stranded nucleic acid molecule
CN109641891B (zh) 新化合物和方法
TW201713652A (zh) 雜環化合物的合成
AU2010289802C1 (en) Synthesis of a neurostimulative piperazine
EP3766869B1 (en) Simple preparation method for avibactam
ES2769255T3 (es) Métodos para fabricar inhibidores de la proteína desacetilasa
US11926633B2 (en) Synthesis methods for upadacitinib and intermediate thereof
JP2020506161A (ja) 5r−ベンジルオキシアミノピペリジン−2s−ギ酸又はその誘導体の調製方法
US20230416243A1 (en) Process for Preparing Heterocyclic Methanone Compounds and AZA-Bicyclo Intermediates Thereof
KR102593509B1 (ko) 질소 머스타드 유도체의 제조 방법
AU2023351959A1 (en) Synthesis methods and intermediates for the production of remibrutinib
CN111943893B (zh) 4,7-二氮杂螺[2,5]辛烷类化合物的合成方法
CN104876872A (zh) 一种制备1-叔丁氧基羰基-3-羟甲基吲唑的方法及应用
EP4259626B1 (en) Process for the preparation 4-(3,5-difluorophenyl)-n-[3-(6-methylpyrimidin-4-yl)-3- azabicyclo[3.2.1]octan-8-yl]-6,7-dihydro-5h-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine
CA3268617A1 (en) Synthesis methods and intermediates
KR20240122751A (ko) 바이사이클릭 글리신-프롤린 화합물 및 이의 모노사이클릭 글리신-프롤린 중간체를 제조하는 방법
CN110573521B (zh) 4’-硫代核苷的新型化合物的制备方法和此制备方法中的中间体
WO2025240628A1 (en) Processes for preparing a pkc inhibitor
WO2013140331A1 (en) New 1, 2, 4-oxadiazol derivatives, process for their preparation and use thereof as intermediates in the preparation of indolic alkaloids
JP2025156267A (ja) エロビキシバット又はその溶媒和物の調製のための方法
WO2026082013A1 (zh) 一种酞嗪酮类prmt5抑制剂及其中间体的制备方法
CN117736221A (zh) 瑞卢戈利中间体化合物及瑞卢戈利的制备方法
Kaiser et al. Formation of N-acyl-N, N′-dicyclohexylureas from DCC and Arenecarboxylic Acids in the Presence of Hydroxybenzotriazole in CH2Cl2 at Room Temperature
CN120957989A (zh) 用于制备氮杂双环杂芳基化合物的流动化学工艺

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230601

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20241029

Comment text: Request for Examination of Application